Overview


According to FutureWise analysis the market for Anti-snoring Devices and Snoring Surgery in 2023 is US$ 1.64 billion, and is expected to reach US$ 2.9 billion by 2031 at a CAGR of 7.40%.

Anti-snoring devices are non-invasive tools or appliances developed to relieve or eliminate the sound and issues associated with snoring during sleep. These devices address the underlying causes of snoring, such as airway blockages or muscle relaxation, to promote better airflow and reduce the vibrations that lead to snoring. Snoring surgery refers to a range of medical procedures that are performed to treat chronic snoring. These surgeries are typically considered when non-invasive methods have proven ineffective. Snoring surgery aims to correct anatomical or structural issues in the throat and airway that contribute to snoring, thereby reducing the severity of snoring. These surgeries can involve the removal, reshaping, or repositioning of tissues in the throat t  o improve airflow and reduce the sound that cause snoring.

Uvulopalatopharyngoplasty (UPPP) is a technique that involves removing the structures in the mouth and pharynx that are causing snoring but do not include the tongue. The excision consists of the uvula and the extremely soft tissue around the pharynx, performed under general anesthesia. The process involves about three weeks of prolonged and often painful recovery. It has a cure rate of about 50% and a low complication rate of 1%. Complications may include hemorrhage, cardiovascular events such as cerebrovascular accidents or myocardial infarctions, and pneumonia.

FutureWise Market Research has published a report that provides an insightful analysis anti-snoring devices and snoring surgery market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry.

According to the analysis conducted by FutureWise research analysts, anti-snoring devices and snoring surgery market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • Sleeping Well, LLC
  • Apnea Sciences Corporation
  • The Pure Sleep Company
  • Somnomed Limited
  • Airway Management Inc.
  • Theravent, Inc.
  • Tomed Dr. Toussaint Gmbh
  • Glaxosmithkline, PLC
  • Meditas Ltd.
  • Innovative Health Technologies (NZ) Limited

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anti-snoring Devices and Snoring Surgery Market:

  • Jul 2022- Glidewell launched a latest addition to its portfolio of mandibular advancement devices, the Silent Nite Sleep Appliance featuring Glidewell Hinge. This innovation is designed for addressing snoring and managing obstructive sleep apnea (OSA) symptoms.
  • In June 2022, Illusion Aligners launched a new anti-snoring device, which is a highly lightweight and user-friendly oral anti-snoring device that effectively addresses symptoms of OSA (obstructive sleep apnea) as well as enhances sound sleep, reduces fatigue, and improves the overall quality of life.

The increasing global prevalence of sleep disorders, including snoring, is rising due to significant factors such as mounting stress levels, obesity, and adopting unhealthy lifestyles. The pressure of modern life has led to stress and anxiety, contributing to sleep disruptions and snoring. Concurrently, the rising prevalence of obesity, often related to sedentary habits and poor dietary preferences, exacerbates airway obstruction during sleep, which is a common trigger for snoring. These trends boost the demand for effective anti-snoring solutions, encouraging individuals to seek remedies that alleviate the health risks and disruptions associated with snoring, therefore fostering a demand for anti-snoring devices and snoring surgery market. Moreover, the prevailing trend towards health and wellness is anticipated to significantly impact individual behaviors, encouraging them to allocate resources to increase their sleep quality. As individuals become increasingly invested in holistic well-being, the tendency to seek out remedies for sleep-related concerns gains importance. This rising awareness of the crucial connection between sleep and overall health propels the interest in seeking solutions that address snoring-related issues. Therefore, this burgeoning interest creates an opportunity for the adoption of anti-snoring devices and snoring surgery market during the forecast period. Furthermore, some anti-snoring devices provide temporary relief but may not offer a permanent solution and are expected to hinder market growth. Given the absence of sustained results, this transitory efficacy may foster a significant constraint by dissuading individuals from committing to repeat purchases. Consequently, this limitation not only hampers the establishment of a loyal consumer base but also propels many to venture into alternative approaches, such as considering more permanent interventions like snoring surgery. Moreover, the lack of scientific validation for various anti-snoring devices is poised to pose a substantial challenge to the growth of the anti-snoring devices and snoring surgery market throghout the forecast period. This skepticism encompassing their efficacy could impede market growth as potential users become cautious about investing in solutions that lack substantial scientific support.

By Type

  • Oral Appliances
    • Mandibular Advancement Devices (MADs)
      • Non-custom MADs
      • Custom-made MADs
    • Tongue-retaining Devices
  • Nasal Devices
    • External Nasal Dilators
    • Other Nasal Devices
  • Position Control Devices
  • Chin Straps
  • Tongue-stabilizing Devices
  • Expiratory Positive Airway Pressure (EPAP) Therapy Devices

By Surgical Procedure

  • Laser-assisted Uvulopalatoplasty
  • Radiofrequency Ablation
  • Pillar Procedure
  • Uvulopalatopharyngoplasty (UPPP)
  • Injection Snoreplasty
  • Palatal Stiffening
  • Other Surgical Procedures

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. Due to the growing geriatric population, technological advancements and innovations in the healthcare industry, high prevalence of snoring, and rising obesity have led to an increased demand for anti-snoring devices in the U.S. region. Moreover, the presence of market players in this region and the availability of products in retail stores and e-commerce sites is expected to boost market and product reach. Additionally, this is attributed to several individuals experiencing snoring problems in the U.S. For instance, as per an article published in 2022 by John Hopkins University, around 45.0% of adults experience occasional snoring, with 25.0% snoring regularly, further driving the market's growth during the projected period in the 
region.

  • Tier 1 players-established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the anti-snoring devices and snoring surgery market By Type, By Surgical procedures and By Region.
  • To cater comprehensive insights on factors such as drivers, restraints, trends, opportunity, and additionally segmental and regional factors impacting market growth.
  • To evaluate current market trends and forecast micro-markets and the overall market projections which are represented in the format of data-sets and ppt.
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa. 
  • To provide information on competitors which includes landscape mapping, technological advancements, R&D spending, news concerning strategic alliances, and new product launches

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

 

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Infertility Drugs and Devices Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Type Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Infertility Drugs and Devices Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Infertility Drugs and Devices Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Type Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Type Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Infertility Drugs and Devices Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Oral Appliances/Mouthpieces
         1.1. Mandibular Advancement Devices (MADS)
          1.1.1. Non-Custom MADS
          1.1.2. Custom-Made MADS
         1.2. Tongue-Retaining Devices (TRDS)
        2. Nasal Devices
         2.1. External Nasal Dilators (Nasal Strips)
         2.2. Other Nasal Devices (Nasal Stents, Nasal Clips, and Septal Stimulators)
        3. Position Control Devices
        4. Chin Straps
        5. Tongue-Stabilizing Devices (TSDs)
        6. Epap Therapy Devices

  • 8.   Infertility Drugs and Devices Market, By Gender Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Uvulopalatopharyngoplasty (UPPP)
        2. Laser-Assisted Uvulopalatoplasty (Laup)
        3. Radiofrequency Ablation (Somnoplasty)
        4. Pillar Procedure
        5. Injection Snoreplasty/Sclerotherapy
        6. Palatal Stiffening Procedures
        7. Other Anti-Snoring Surgical Procedures

  • 9.   North America Infertility Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 10.   Latin America Infertility Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 11.   Europe Infertility Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 12.   Asia Pacific Infertility Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 13.   Middle East and Africa Infertility Drugs and Devices Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 14.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 15.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Sleeping Well, LLC
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Apnea Sciences Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. The Pure Sleep Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Somnomed Limited
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Airway Management Inc.
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Theravent, Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Tomed Dr. Toussaint Gmbh
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Glaxosmithkline, PLC
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Meditas Ltd.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Innovative Health Technologies (NZ) Limited
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 16.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 17.   FutureWise SME Key Takeaway Points for Client

Related Market

Anti-Snoring Treatment Market

Read More
Partner

Our Clients